000 01060 a2200301 4500
005 20250515173828.0
264 0 _c20100319
008 201003s 0 0 eng d
022 _a1365-2230
024 7 _a10.1111/j.1365-2230.2008.03151.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHussain, W
245 0 0 _aThe role of imiquimod in treating infantile haemangiomas: cause for concern?
_h[electronic resource]
260 _bClinical and experimental dermatology
_cOct 2009
300 _ae257 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAminoquinolines
_xadverse effects
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHemangioma
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aImiquimod
650 0 4 _aInfant
650 0 4 _aSkin Neoplasms
_xdrug therapy
700 1 _aJudge, M R
773 0 _tClinical and experimental dermatology
_gvol. 34
_gno. 7
_gp. e257
856 4 0 _uhttps://doi.org/10.1111/j.1365-2230.2008.03151.x
_zAvailable from publisher's website
999 _c18931884
_d18931884